In this issue of Gastroenterology Clinics, guest editors Dr. Colleen R. Kelly brings her considerable expertise to the topic of Mastering Clostridioides difficile Infection: Comprehensive Insights and Patient-Focused Care. Increasing rates of C. difficile infection, specifically community-acquired and multiply recurrent infections, have occurred over the past 20 years. In the era of nucleic acid amplification-based testing, diagnostic challenges have become apparent, and making an accurate diagnosis is important given newer therapeutic options for treatment and prevention of recurrence. This issue provides the most current information on management of C. difficile infection with the goal of improving patient outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Preface - p. xi 9. The Changing Epidemiology of Clostridioides difficile Infection - p. 389 10. Strategies for the Prevention of Clostridioides difficile Infections - p. 403 11. Understanding the Pathophysiology of Clostridioides difficile Infection, Colonization, and Making an Accurate Diagnosis - p. 419 12. Probiotics for Primary or Secondary Prevention of Clostridioides difficile Infection - p. 433 13. Non-Severe Clostridium difficile Infection - p. 447 14. Treatment of Severe and Fulminant Clostridioides difficile Infections - p. 459 15. Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease - p. 473 16. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection - p. 485 17. Non-Fecal Microbiota Transplantation Strategies for Treatment of Recurrent Clostridioides difficile Infection - p. 493 18. Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection - p. 503
In this issue of Gastroenterology Clinics, guest editors Dr. Colleen R. Kelly brings her considerable expertise to the topic of Mastering Clostridioides difficile Infection: Comprehensive Insights and Patient-Focused Care. Increasing rates of C. difficile infection, specifically community-acquired and multiply recurrent infections, have occurred over the past 20 years. In the era of nucleic acid amplification-based testing, diagnostic challenges have become apparent, and making an accurate diagnosis is important given newer therapeutic options for treatment and prevention of recurrence. This issue provides the most current information on management of C. difficile infection with the goal of improving patient outcomes.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Preface - p. xi 9. The Changing Epidemiology of Clostridioides difficile Infection - p. 389 10. Strategies for the Prevention of Clostridioides difficile Infections - p. 403 11. Understanding the Pathophysiology of Clostridioides difficile Infection, Colonization, and Making an Accurate Diagnosis - p. 419 12. Probiotics for Primary or Secondary Prevention of Clostridioides difficile Infection - p. 433 13. Non-Severe Clostridium difficile Infection - p. 447 14. Treatment of Severe and Fulminant Clostridioides difficile Infections - p. 459 15. Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease - p. 473 16. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection - p. 485 17. Non-Fecal Microbiota Transplantation Strategies for Treatment of Recurrent Clostridioides difficile Infection - p. 493 18. Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection - p. 503
